Gentronix Recognised With King’s Award After Record International Growth
2024年5月7日 - 7:03PM
ビジネスワイヤ(英語)
UK-based Contract Research Organisation (CRO) Gentronix – a
leading specialist toxicology firm based at Alderley Park – has
been awarded the King’s Award for Enterprise after achieving a
triple-figure revenue growth following rapid expansion in
international markets.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240507716487/en/
Gentronix Recognised With King’s Award
After Record International Growth (Photo: Business Wire)
Gentronix recorded total growth of 239% in overseas earnings
over the past three years, with the percentage of total sales
exported rising from 71% to 81% over the same period, driving
revenue to in excess of £10m per annum. The US has been a
particularly strong area of growth and this market now makes up
almost half of the firm’s international business, with demand
continuing to increase across North America.
As a result of the business’s success and enhanced overseas
trading, Gentronix has received a prestigious King’s Award for
Enterprise for 2024, marking its success in the area of
International Trade.
Along with its UK and US client base, Gentronix also supplies
its services to a growing number of international customers
including in the EU, Switzerland and Japan.
To support this exceptional growth, the business has also
expanded laboratory space at its home at Alderley Park in Cheshire
by 30% - an additional 5,000 sq. ft - and increased its headcount
to 67, with further investment continuing in 2024 and 2025. Its
workforce supports the needs of seven of the top 10 global pharma
companies.
Gentronix’s growth and expansion has further strengthened its
ability to support clients in meeting their regulatory
requirements, identifying potential hazards within project
pipelines and managing risk for their materials.
Its ongoing growth strategy and rising global demand for its
services has also enabled it to create more than 30 new job
opportunities for scientists in the North West of England in the
last three years.
CEO at Gentronix, Matt Tate, said: “The past three years
have been extremely successful for the business as we continue on
our long-term growth journey, and it has been especially satisfying
to provide our services to new customers across the globe.
“We remain committed to offering best-in-class toxicology
services to our expanding client base, whilst creating more
opportunities for talented scientists in the North West, without
whom we wouldn’t have been able to achieve any of this.
“To be recognised with a King’s Award is a fabulous achievement
and is testament to the exceptional work that the entire team has
put into realising our growth ambitions and cementing our
credentials as a truly international business.”
As a leading predictive toxicology CRO, operating from its GLP
laboratory base at Alderley Park, UK, Gentronix’s work helps
develop safe products used by millions of people around the world
including pharmaceuticals, agrochemicals, fragrances, foods,
flavours, personal care products and cosmetics.
For more information about Gentronix, please visit the
website.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507716487/en/
ben.rowe@thisisdefinition.com / 07402 325645